Recipharm Pharmaservices Private Limited – FDA 483, Feb 13, 2020
An FDA inspection of Recipharm Pharmaservices Private Limited, a drug manufacturer in Bangalore, Karnataka, India, revealed significant deficiencies in equipment management and electronic recordkeeping. The firm failed to perform routine inspections of automatic, mechanical, and electronic equipment according to a written program, and electronic records lacked proper retention, system access limitations, and audit trails. These issues compromise the trustworthiness and reliability of critical data, indicating serious quality control and data integrity concerns.
ID · 526cedaa-2184-4035-ba1a-74360cb81877
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.